Breaking Barriers: Gut Pathobionts Promote Hepatocellular Carcinoma.

Gut pathobionts, especially Bacteroides fragilis, translocate via the gut-liver axis, colonize the liver, and promote hepatocellular carcinoma through bacterial enolase binding hepatocyte vimentin.

• Why it matters: The origin and functional role of liver and intratumoral microbiota in HCC are unclear, limiting understanding of how the gut-liver axis may contribute to tumor development.
• What they did: Liu and colleagues tracked gut pathobionts through the gut-liver axis, assessed how they reshape the intrahepatic microbiome, and identified a mechanism where bacterial enolase binds hepatocyte vimentin.
• The result: The findings link gut-derived microbes to intratumoral microbiome changes and suggest therapeutic opportunities targeting this enolase–vimentin interaction.

AI summary of the abstract · may contain errors · not medical advice · read the paper.